María Asunción E. P.
- Country
- Spain
- Department
- Cardiology
Research Overview
Data & Insights
Has run more than one trial at 0 of 7 partner sites.
Specializations
Cardiovascular Atherosclerosis and Lipid Management
The investigator concentrates on the prevention and treatment of atherosclerotic cardiovascular disease and associated lipid abnormalities, emphasizing risk reduction in patients with elevated lipoprotein(a) and dyslipidemia.
- ASCVD
- elevated lipoprotein(a)
- dyslipidemia
- obesity‑related cardiovascular risk
These focus areas support primary and secondary prevention strategies across diverse patient populations.
Acute Coronary Syndromes and Myocardial Infarction
Research efforts target the rapid diagnosis, acute management, and post‑event care of acute coronary syndrome and myocardial infarction, including both STEMI and NSTEMI presentations.
- ST‑elevation myocardial infarction
- non‑ST‑elevation myocardial infarction
- unstable angina
- revascularization outcomes
The work aims to improve early therapeutic intervention and long‑term cardiovascular health.
Heart Failure and Cardiomyopathy
Dedicated to the spectrum of heart failure phenotypes, the investigator explores therapeutic pathways for reduced and preserved ejection fraction, as well as genetic cardiomyopathies.
- heart failure with reduced ejection fraction
- heart failure with preserved ejection fraction
- dilated cardiomyopathy
- hypertrophic cardiomyopathy
These initiatives address disease progression, quality of life, and mortality reduction.
Atrial Fibrillation and Thromboembolic Prevention
The investigator’s portfolio includes the management of atrial fibrillation and strategies to prevent stroke and systemic embolism in high‑risk patients.
- anticoagulation in atrial fibrillation
- stroke prevention
- cardioembolic risk assessment
- rate and rhythm control
Efforts focus on balancing efficacy and safety in anticoagulant therapy.
Vascular and Metabolic Risk Factors
Beyond overt cardiac disease, the investigator examines the impact of systemic conditions such as hypertension, diabetes mellitus, and metabolic syndrome on vascular health.
- hypertension management
- diabetes‑related cardiovascular risk
- metabolic syndrome
- renal‑cardiac interaction
This integrative approach supports comprehensive cardiovascular risk reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.